Cabaylo, Victoria M.
HRN: 25-54-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/26/2024
08/02/2024
IV
600mg
Q6H
INFECTED WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes